{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:40Z","timestamp":1772165680194,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11699-4","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:44:04Z","timestamp":1761655444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of the alpha-1 antitrypsin in the progression and severity of COVID-19 infection among Saudi patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Rabab A.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa A.","family":"Mohammedsaeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Hisham A.","family":"Fakher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala K.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir M.","family":"Al Qurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"4","key":"11699_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10456-021-09805-6","volume":"24","author":"DM Smadja","year":"2021","unstructured":"Smadja DM, Mentzer SJ, Fontenay M, Laffan MA, Ackermann M, Helms J, et al. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021;24(4):755\u201388.","journal-title":"Angiogenesis"},{"issue":"3","key":"11699_CR2","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1042\/BST20230078","volume":"51","author":"X Bai","year":"2023","unstructured":"Bai X, Schountz T, Buckle AM, Talbert JL, Sandhaus RA, Chan ED. Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence. Biochem Soc Trans. 2023;51(3):1361\u201375.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"11699_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11894-006-0059-8","volume":"8","author":"JH Teckman","year":"2006","unstructured":"Teckman JH, Lindblad D. Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management. Curr Gastroenterol Rep. 2006;8(1):14\u201320.","journal-title":"Curr Gastroenterol Rep"},{"key":"11699_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2147\/COPD.S125389","volume":"12","author":"I Blanco","year":"2017","unstructured":"Blanco I, Bueno P, Diego I, P\u00e9rez-Holanda S, Casas-Maldonado F, Esquinas C, et al. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update. Int J Chron Obstruct Pulmon Dis. 2017;12:561\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"11699_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1753465812457113","volume":"6","author":"FJ de Serres","year":"2012","unstructured":"de Serres FJ, Blanco I. Prevalence of \u03b11-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis. 2012;6(5):277\u201395.","journal-title":"Ther Adv Respir Dis"},{"issue":"1","key":"11699_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.20411\/pai.v6i1.408","volume":"6","author":"NP Azouz","year":"2021","unstructured":"Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, et al. Alpha 1 antitrypsin is an inhibitor of the SARS-CoV-2-priming protease TMPRSS2. Pathog Immun. 2021;6(1):55\u201374.","journal-title":"Pathog Immun"},{"key":"11699_CR7","doi-asserted-by":"publisher","first-page":"615398","DOI":"10.3389\/fphar.2020.615398","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang C, Keshavjee S, Liu M. Alpha-1 antitrypsin for COVID-19 treatment: dual role in antiviral infection and anti-inflammation. Front Pharmacol. 2020;11:615398.","journal-title":"Front Pharmacol"},{"issue":"8","key":"11699_CR8","first-page":"2348","volume":"11","author":"TJ Craig","year":"2023","unstructured":"Craig TJ, Corbett ML, Meadows JA. Improving detection of alpha-1 antitrypsin deficiency: role of the allergist. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(8):2348\u201354.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"key":"11699_CR9","doi-asserted-by":"publisher","first-page":"m1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.","journal-title":"BMJ"},{"issue":"10229","key":"11699_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"11","key":"11699_CR11","doi-asserted-by":"publisher","first-page":"14160","DOI":"10.1096\/fj.202002097","volume":"34","author":"G Shapira","year":"2020","unstructured":"Shapira G, Shomron N, Gurwitz D. Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates. FASEB J. 2020;34(11):14160\u20135.","journal-title":"FASEB J"},{"key":"11699_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106440","volume":"183","author":"I Ferrarotti","year":"2021","unstructured":"Ferrarotti I, Ottaviani S, Balderacchi AM, Barzon V, De Silvestri A, Piloni D, et al. COVID-19 infection in severe alpha 1-antitrypsin deficiency: looking for a rationale. Respir Med. 2021;183:106440.","journal-title":"Respir Med"},{"issue":"1","key":"11699_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1183\/09031936.06.00062305","volume":"27","author":"I Blanco","year":"2006","unstructured":"Blanco I, de Serres FJ, Fernandez-Bustillo E, Lara B, Miravitlles M. Estimated numbers and prevalence of PI*S and PI*Z alleles of \u03b1 <\u2009sub\u2009>\u20091-antitrypsin deficiency in European countries. Eur Respir J. 2006;27(1):77\u201384.","journal-title":"Eur Respir J"},{"issue":"2","key":"11699_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.35772\/ghm.2020.01068","volume":"3","author":"H Yoshikura","year":"2021","unstructured":"Yoshikura H. Epidemiological correlation between COVID-19 epidemic and prevalence of \u03b1-1 antitrypsin deficiency in the world. Glob Health Med. 2021;3(2):73\u201381.","journal-title":"Glob Health Med"},{"key":"11699_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106466","volume":"184","author":"CV Schneider","year":"2021","unstructured":"Schneider CV, Strnad P. SARS-CoV-2 infection in alpha1-antitrypsin deficiency. Respir Med. 2021;184:106466.","journal-title":"Respir Med"},{"key":"11699_CR16","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.2147\/IJGM.S370434","volume":"15","author":"D Nygren","year":"2022","unstructured":"Nygren D, M\u00f6lstad U, Thulesius H, Hillman M, Broman LM, Tanash H, et al. Low prevalence of mild alpha-1-antitrypsin deficiency in hospitalized COVID-19-patients. Int J Gen Med. 2022;15:5843\u20138.","journal-title":"Int J Gen Med"},{"key":"11699_CR17","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2147\/COPD.S137852","volume":"12","author":"I Blanco","year":"2017","unstructured":"Blanco I, Bueno P, Diego I, P\u00e9rez-Holanda S, Lara B, Casas-Maldonado F, et al. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide. Int J Chron Obstruct Pulmon Dis. 2017;12:1683\u201394.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"11699_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijcard.2020.04.009","volume":"312","author":"JZ Wang","year":"2020","unstructured":"Wang JZ, Zhang RY, Bai J. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int J Cardiol. 2020;312:137\u20138.","journal-title":"Int J Cardiol"},{"issue":"12","key":"11699_CR19","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1515\/CCLM.2000.198","volume":"38","author":"A Piwowar","year":"2000","unstructured":"Piwowar A, Knapik-Kordecka M, Warwas M. Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin Chem Lab Med. 2000;38(12):1257\u201361.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"11699_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diabres.2009.03.003","volume":"84","author":"M Yaghmaei","year":"2009","unstructured":"Yaghmaei M, Hashemi, Shikhzadeh MA, Mokhtari M, Niazi A, Ghavami S. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus. Diabetes Res Clin Pract. 2009;84(3):201\u20134.","journal-title":"Diabetes Res Clin Pract"},{"key":"11699_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2019.01.014","volume":"189","author":"S Dimeloe","year":"2019","unstructured":"Dimeloe S, Rice LV, Chen H, Cheadle C, Raynes J, Pfeffer P, et al. Vitamin D (1,25(OH)2D3) induces \u03b1-1-antitrypsin synthesis by CD4\u2009+\u2009T cells, which is required for 1,25(OH)2D3-driven IL-10. J Steroid Biochem Mol Biol. 2019;189:1\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"11699_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/advances\/nmab012","volume":"12","author":"A Kazemi","year":"2021","unstructured":"Kazemi A, Mohammadi V, Aghababaee SK, Golzarand M, Clark CT, Babajafari S. Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis. Adv Nutr. 2021;12(5):1636\u201358.","journal-title":"Adv Nutr"},{"issue":"1","key":"11699_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77093-z","volume":"10","author":"A Jain","year":"2020","unstructured":"Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers. Sci Rep. 2020;10(1):20191.","journal-title":"Sci Rep"},{"issue":"5","key":"11699_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052441","volume":"23","author":"ME O\u2019Brien","year":"2022","unstructured":"O\u2019Brien ME, Murray G, Gogoi D, Yusuf A, McCarthy C, Wormald MR, et al. A review of alpha-1 antitrypsin binding partners for immune regulation and potential therapeutic application. Int J Mol Sci. 2022;23(5):2441.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11699_CR25","first-page":"97","volume":"14","author":"M Farcas","year":"2009","unstructured":"Farcas M, Csernik F, Popp R-A, Trifa A, Crisan T, Petrisor F, et al. The Interleukin 4 VNTR polymorphism frequency in a Romanian population group. Annals Romanian Soc Cell Biology. 2009;14(1):97\u2013101.","journal-title":"Annals Romanian Soc Cell Biology"},{"issue":"6","key":"11699_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","volume":"202","author":"OJ McElvaney","year":"2020","unstructured":"McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202(6):812\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"11699_CR27","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","volume":"130","author":"SF Pedersen","year":"2020","unstructured":"Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202\u20135.","journal-title":"J Clin Invest"},{"issue":"2","key":"11699_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/biomedicines11020516","volume":"11","author":"JL Rodr\u00edguez Hermosa","year":"2023","unstructured":"Rodr\u00edguez Hermosa JL, Vargas Centanaro G, Gonz\u00e1lez Castro ME, Miravitlle M, L\u00e1zaro-Asegurado, Jim\u00e9nez-Rodr\u00edguez BM, et al. Severe COVID-19 illness and \u03b11-antitrypsin deficiency: COVID-AATD study. Biomedicines. 2023;11(2):516.","journal-title":"Biomedicines"},{"key":"11699_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.biochi.2022.07.012","volume":"202","author":"A Philippe","year":"2022","unstructured":"Philippe A, Puel M, Narjoz C, Gendron N, Durey-Dragon MA, Vedie B, et al. Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19. Biochimie. 2022;202:206\u201311.","journal-title":"Biochimie"},{"issue":"4","key":"11699_CR30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/antiox12040872","volume":"12","author":"M Magall\u00f3n","year":"2023","unstructured":"Magall\u00f3n M, Castillo-Corull\u00f3n S, Ba\u00f1uls L, Pellicer D, Romero T, Mart\u00ednez-Ferraro C, et al. Hypoxia enhances oxidative stress in neutrophils from ZZ alpha-1 antitrypsin deficiency patients. Antioxidants. 2023;12(4):872.","journal-title":"Antioxidants"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11699-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11699-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11699-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:05:24Z","timestamp":1761696324000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11699-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11699"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11699-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4725061\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Saudi Arabia Ministry of Health\u2019s (MOH) General Administration for Research & Studies (IRB) and faculty of Applied Medical Sciences at Taibah University provided ethical approval (approved IRB-452, Date: 24\/4\/2020) for the study to be conducted in compliance with the Declaration of Helsinki. Since only leftover whole blood samples were utilized in the non-invasive study design, the ethical committee waived the need for written informed permission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1422"}}